Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.170
0.000
Volume:81.52K
Turnover:423.60K
Market Cap:4.21B
PE:-22.16
High:5.275
Open:5.170
Low:5.150
Close:5.170
52wk High:10.940
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.76
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-3.45%
ROA:-1.93%
PB:1.00
PE(LYR):-22.16
PS:3.87

Loading ...

Warburg Pincus in Advanced Talks for $7B+ Acquisition of Rare Disease Pharma Pantherx with ADIA

Deep News
·
Jul 12

ASCLETIS-B Executes Share Buyback, Spending HK$1.119 Million

Stock News
·
Jul 08

ASCLETIS-B Executes Share Buyback on July 7, Spending HK$1.153 Million

Stock News
·
Jul 07

Fresh Legal Filings Submitted for Investor Claims Against Zitian Tech and Poly Pharm

Deep News
·
Jul 06

Ocumension Therapeutics Says Tim Ruan Resigns as CFO

Reuters
·
Jul 06

Frequent Price Fluctuations and Policy Tailwinds: Is a Pharmaceutical Rally Brewing?

Deep News
·
Jul 06

ASCLETIS-B Submits Two IND Applications to US FDA for Obesity Treatments: Monthly Peptide Amylin Receptor Agonist ASC36 and ASC36_35 Combination Monthly Injection

Stock News
·
Jul 06

Pharmaceutical Giant Appoints AI Executive to Lead Digital Innovation

Deep News
·
Jul 04

Ocumension Jumps Most in Three Months on China Nod for New Drug Application

Reuters
·
Jul 03

Ocumension Says China NMPA Approves Ot-502 New Drug Application for Postoperative Ocular Inflammation

Reuters
·
Jul 02

Ocumension Therapeutics - Nmpa Approves Ot-502 (dexycu) New Drug Application in China

THOMSON REUTERS
·
Jul 02

Investor Compensation Cases for Changyao Holdings and Poly Pharmaceutical Set for Court Proceedings

Deep News
·
Jul 02

Huiyu Pharmaceutical Inks Strategic Partnership Deal with Avenacy

Stock News
·
Jul 02

Anthropic Launches Internal Drug Discovery Initiative and AI Research Platform, Focusing on Neglected Diseases

Deep News
·
Jul 01

Anthropic Launches Claude Science to Revolutionize Research and Drug Discovery

Stock News
·
Jul 01

Ocumension Therapeutics Says Tim Ruan Resigns as CFO

Reuters
·
Jun 30

Ocumension Therapeutics Announces CFO Departure and Corporate Secretary Restructure

Bulletin Express
·
Jun 30

Ocumension Therapeutics - Tim Ruan Resigns as CFO, Joint Company Secretary, and Authorized Representative Effective June 30, 2026

THOMSON REUTERS
·
Jun 30

Ocumension details updated board composition and committee assignments

Bulletin Express
·
Jun 30

Ocumension Therapeutics: AGM Approves All Motions; Beibei Zhuang Appointed Independent Director and Audit Chair

Bulletin Express
·
Jun 30